Q1 2025 13F Holders as of 3/31/2025
-
Type / Class
-
Equity / ADR
-
Shares outstanding
-
50.2M
-
Number of holders
-
115
-
Total 13F shares, excl. options
-
47.3M
-
Shares change
-
+2.03M
-
Total reported value, excl. options
-
$1.4B
-
Value change
-
+$60.3M
-
Put/Call ratio
-
0.55
-
Number of buys
-
57
-
Number of sells
-
-46
-
Price
-
$29.67
Significant Holders of Immunocore Holdings plc - ADR (IMCR) as of Q1 2025
139 filings reported holding IMCR - Immunocore Holdings plc - ADR as of Q1 2025.
Immunocore Holdings plc - ADR (IMCR) has 115 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 47.3M shares
of 50.2M outstanding shares and own 94.14% of the company stock.
Largest 10 shareholders include T. Rowe Price Investment Management, Inc. (7.05M shares), WELLINGTON MANAGEMENT GROUP LLP (6.13M shares), RTW INVESTMENTS, LP (4.87M shares), FMR LLC (4.84M shares), PRIMECAP MANAGEMENT CO/CA/ (2.68M shares), BAKER BROS. ADVISORS LP (2.32M shares), TANG CAPITAL MANAGEMENT LLC (1.92M shares), PRICE T ROWE ASSOCIATES INC /MD/ (1.89M shares), Kynam Capital Management, LP (1.7M shares), and Deep Track Capital, LP (1.41M shares).
This table shows the top 115 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.